TNBCPD-L1

Robbe Salembier1,2, Caro De Haes1,2, Kristel Demeyere1

  • 1Laboratory of Biochemistry, Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

NPJ breast cancer
|December 26, 2025
PubMed
概括

三重阴性乳腺癌 (TNBC) 对免疫治疗的反应有所不同. 鼠标模型显示,免疫抑制性髓状细胞和与癌症相关的纤维细胞驱动对PD-L1阻塞的抵抗,无论瘤炎症如何.